| GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes MK Nøhr, MH Pedersen, A Gille, KL Egerod, MS Engelstoft, AS Husted, ... Endocrinology 154 (10), 3552-3564, 2013 | 534 | 2013 |
| Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1 C Morland, KA Andersson, ØP Haugen, A Hadzic, L Kleppa, A Gille, ... Nature communications 8 (1), 15557, 2017 | 442 | 2017 |
| An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81 K Ahmed, S Tunaru, C Tang, M Müller, A Gille, A Sassmann, J Hanson, ... Cell metabolism 11 (4), 311-319, 2010 | 409 | 2010 |
| GPR109A (PUMA-G/HM74A) mediates nicotinic acid–induced flushing Z Benyó, A Gille, J Kero, M Csiky, MC Suchánková, RM Nüsing, A Moers, ... The Journal of clinical investigation 115 (12), 3634-3640, 2005 | 391 | 2005 |
| Nicotinic acid: pharmacological effects and mechanisms of action A Gille, ET Bodor, K Ahmed, S Offermanns Annu. Rev. Pharmacol. Toxicol. 48, 79-106, 2008 | 368 | 2008 |
| Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes C Tang, K Ahmed, A Gille, S Lu, HJ Gröne, S Tunaru, S Offermanns Nature medicine 21 (2), 173-177, 2015 | 333 | 2015 |
| Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells M Lukasova, C Malaval, A Gille, J Kero, S Offermanns The Journal of clinical investigation 121 (3), 1163-1173, 2011 | 285 | 2011 |
| Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells Z Benyo, A Gille, CL Bennett, BE Clausen, S Offermanns Molecular pharmacology 70 (6), 1844-1849, 2006 | 260 | 2006 |
| Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia MK Nøhr, KL Egerod, SH Christiansen, A Gille, S Offermanns, ... Neuroscience 290, 126-137, 2015 | 242 | 2015 |
| Nicotinic acid–and monomethyl fumarate–induced flushing involves GPR109A expressed by keratinocytes and COX-2–dependent prostanoid formation in mice J Hanson, A Gille, S Zwykiel, M Lukasova, BE Clausen, K Ahmed, ... The Journal of clinical investigation 120 (8), 2910-2919, 2010 | 217 | 2010 |
| Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux S Diditchenko, A Gille, I Pragst, D Stadler, M Waelchli, R Hamilton, A Leis, ... Arteriosclerosis, thrombosis, and vascular biology 33 (9), 2202-2211, 2013 | 145 | 2013 |
| Inhibitors of membranous adenylyl cyclases R Seifert, GH Lushington, TC Mou, A Gille, SR Sprang Trends in pharmacological sciences 33 (2), 64-78, 2012 | 120 | 2012 |
| Infusion of Reconstituted High‐Density Lipoprotein, CSL 112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial P Tricoci, DM D'Andrea, PA Gurbel, Z Yao, M Cuchel, B Winston, R Schott, ... Journal of the American Heart Association 4 (8), e002171, 2015 | 119 | 2015 |
| Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides A Gille, GH Lushington, TC Mou, MB Doughty, RA Johnson, R Seifert Journal of Biological Chemistry 279 (19), 19955-19969, 2004 | 116 | 2004 |
| CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects A Gille, R Easton, D D’Andrea, SD Wright, CL Shear Arteriosclerosis, thrombosis, and vascular biology 34 (9), 2106-2114, 2014 | 114 | 2014 |
| Enhanced HDL functionality in small HDL species produced upon remodeling of HDL by reconstituted HDL, CSL112: effects on cholesterol efflux, anti-inflammatory and antioxidative … SA Didichenko, AV Navdaev, AMO Cukier, A Gille, P Schuetz, ... Circulation research 119 (6), 751-763, 2016 | 105 | 2016 |
| A multiple ascending dose study of CSL112, an infused formulation of ApoA‐I R Easton, A Gille, D D'Andrea, R Davis, SD Wright, C Shear The Journal of Clinical Pharmacology 54 (3), 301-310, 2014 | 93 | 2014 |
| Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2′(3′)-O-(N-methylanthraniloyl)-guanosine 5′-triphosphate TC Mou, A Gille, DA Fancy, R Seifert, SR Sprang Journal of Biological Chemistry 280 (8), 7253-7261, 2005 | 87 | 2005 |
| Alignment-Annotator web server: rendering and annotating sequence alignments C Gille, M Fähling, B Weyand, T Wieland, A Gille Nucleic acids research 42 (W1), W3-W6, 2014 | 70 | 2014 |
| CSL112 (apolipoprotein AI [human]) enhances cholesterol efflux similarly in healthy individuals and stable atherosclerotic disease patients A Gille, D D’Andrea, MA Tortorici, G Hartel, SD Wright Arteriosclerosis, thrombosis, and vascular biology 38 (4), 953-963, 2018 | 69 | 2018 |
Samuel D. WrightPharmaceutical ConsultantVerified email at cslbehring.com
